Extensive research confirms unparalleled range of effects Day 0 through 1 year

Proven technology backed by:

  • One year clinical histology
  • 500 clinical study treatments
  • 6 years technology development
  • 3 years pre-clinical & clinical testing
  • 25 completed and ongoing studies

1 year histology shows continuing neocollagenesis and healthier skin



From superficial epidermal to deeper dermal treatment, Portrait® PSR³ yields the therapeutic results patients and physicians desire with an optimized recovery profile.

  • Low morbidity, erythema and recovery time
  • Continuing regenerative process producing sustainable improvements in photodamage
  • Progressive replacement of old thermally modified architecture by new architecture
  • Regenerated reticular architecture of the upper dermis and DE junction
  • Fibroblasts from deeper dermis migrate to support improvement of skin’s architecture and surface
  • Restoration of more normal mechanical and physiological functions of the dermis

Unique thermal profile distinguishes new plasma technology

  • Non-contact millisecond pulses of nitrogen plasma energy
  • Non-chromophore dependent energy absorption
  • Uniform, predictable, non-ablative impact at all energy levels
  • Thermal energy absorbed by all components of the skin’s architecture
  • Unique skin surface microenvironment
    • Epidermis and stratum corneum intact at time of treatment
    • No wound created, epidermal vaporization or charring
    • Intact epithelium immediately post treatment protects and speeds healing
  • Vacuolation of epidermis acts as insulator at high energy
  • Easy to feather treatment areas
  • No scarring or hypopigmentation in clinical studies to date

Review these clinical papers to learn more about plasma skin regeneration or download our latest brochure.

Home | Privacy Statement | Contact | Site Map
©2006 Rhytec, Inc. Portrait and Portrait PSR3 are registered trademarks of Rhytec, Inc. True Regenerative Science and High-Def Marketing are trademarks of Rhytec, Inc. All rights reserved.